Strontium functionalized scaffold for bone tissue engineering

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Drug-eluting scaffolds enhance local delivery of osteoprotective drugs.
• This approach aims to reduce drug dosage and systemic side effects.
• Poly-(ε) caprolactone (PCL) is a biocompatible polymer used in medical devices.

Purpose of the Study:

• To evaluate a novel poly-(ε) caprolactone (PCL)-laponite-strontium ranelate (SRA) composite scaffold (PLS3).
• To assess the scaffold's capacity to support human marrow derived stromal stem cells (hMSC) growth and osteogenic differentiation.
• To investigate the in vivo performance of the hMSC-seeded PLS3 scaffold for bone regeneration.

Main Methods:

• In vitro culture of hMSC on PLS3 scaffolds.
• Assessment of cell proliferation and osteogenic marker expression.
• In vivo implantation of hMSC-seeded PLS3 scaffolds in immunocompromised mice.
• Histological analysis to evaluate ectopic bone formation and vascularization.

Main Results:

• The PLS3 scaffold demonstrated robust support for hMSC proliferation in vitro.
• Significant osteogenic differentiation of hMSC was observed on the PLS3 scaffold.
• In vivo studies revealed vascularized ectopic bone formation following scaffold implantation.
• The composite scaffold facilitated bone regeneration in a non-osseous site.

Conclusions:

• The PLS3 scaffold effectively supports hMSC growth and osteogenic differentiation.
• PLS3 scaffolds show promise for bone regenerative applications in orthopedics and dentistry.
• This composite material offers a potential solution for localized drug delivery in bone repair.